Cargando…
Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment
Anti-PD-1 therapy has revolutionized the clinical treatment of lung cancer. With the increasing number of lung cancer patients being treated, there is also an increase in the number of immune-related adverse events (irAEs) being reported. These irAEs involve multiple organs and systems, mainly manif...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175899/ https://www.ncbi.nlm.nih.gov/pubmed/34094910 http://dx.doi.org/10.3389/fonc.2021.628243 |